ATE486633T1 - Feste pharmazeutische zusammensetzung mit telithromycin - Google Patents

Feste pharmazeutische zusammensetzung mit telithromycin

Info

Publication number
ATE486633T1
ATE486633T1 AT06725981T AT06725981T ATE486633T1 AT E486633 T1 ATE486633 T1 AT E486633T1 AT 06725981 T AT06725981 T AT 06725981T AT 06725981 T AT06725981 T AT 06725981T AT E486633 T1 ATE486633 T1 AT E486633T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
composition containing
solid pharmaceutical
telithromycin
containing telithromycin
Prior art date
Application number
AT06725981T
Other languages
English (en)
Inventor
Christian Desesquelle
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35106715&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE486633(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE486633T1 publication Critical patent/ATE486633T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06725981T 2005-02-25 2006-02-23 Feste pharmazeutische zusammensetzung mit telithromycin ATE486633T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0501936A FR2882522B1 (fr) 2005-02-25 2005-02-25 Composition pharmaceutique solide comprenant de la telithromycine
PCT/FR2006/000411 WO2006090067A1 (fr) 2005-02-25 2006-02-23 Composition pharmaceutique solide comprenant de la telithromycine

Publications (1)

Publication Number Publication Date
ATE486633T1 true ATE486633T1 (de) 2010-11-15

Family

ID=35106715

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06725981T ATE486633T1 (de) 2005-02-25 2006-02-23 Feste pharmazeutische zusammensetzung mit telithromycin

Country Status (29)

Country Link
US (2) US20080113020A1 (de)
EP (1) EP1855695B1 (de)
JP (1) JP5063368B2 (de)
KR (1) KR101346453B1 (de)
CN (1) CN101180064B (de)
AR (1) AR053144A1 (de)
AT (1) ATE486633T1 (de)
AU (1) AU2006217814B2 (de)
BR (1) BRPI0608395A2 (de)
CA (1) CA2598210A1 (de)
CY (1) CY1111129T1 (de)
DE (1) DE602006017975D1 (de)
DK (1) DK1855695T3 (de)
ES (1) ES2354906T3 (de)
FR (1) FR2882522B1 (de)
HK (1) HK1120412A1 (de)
HR (1) HRP20110089T1 (de)
IL (1) IL185251A (de)
ME (1) ME01936B (de)
MX (1) MX2007010405A (de)
MY (1) MY145394A (de)
PL (1) PL1855695T3 (de)
PT (1) PT1855695E (de)
RS (1) RS51578B (de)
RU (1) RU2371184C2 (de)
SI (1) SI1855695T1 (de)
TW (1) TWI371280B (de)
UY (1) UY29403A1 (de)
WO (1) WO2006090067A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2882522B1 (fr) 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
CN102499936B (zh) * 2011-12-01 2013-06-26 西北农林科技大学 一种复方泰利霉素纳米乳口服液及其制备方法
WO2017061431A1 (ja) * 2015-10-05 2017-04-13 富山化学工業株式会社 ソリスロマイシンを含む錠剤
AU2017206672A1 (en) * 2016-01-12 2018-08-23 Wockhardt Limited Pharmaceutical compositions
WO2020021574A1 (en) * 2018-07-27 2020-01-30 Wockhardt Limited Pharmaceutical compositions and methods

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719587B1 (fr) 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
AR024353A1 (es) * 1999-06-15 2002-10-02 He Chunhong Audifono y equipo auxiliar interactivo con relacion de voz a audio remanente
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
FR2826274B1 (fr) * 2001-06-21 2003-09-26 Aventis Pharma Sa Formulation pharmaceutique au gout masque et son procede de preparation
KR100487137B1 (ko) * 2002-07-12 2005-05-03 주식회사 하이닉스반도체 반도체 소자의 제조 방법
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
US20040013737A1 (en) 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
AU2003274927A1 (en) * 2002-08-23 2004-03-11 Genome Therapeutics Corporation Methods and reagents for preventing bacteremias
WO2004019907A1 (en) * 2002-08-29 2004-03-11 Activbiotics, Inc. Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
GB0230034D0 (en) * 2002-12-23 2003-01-29 Biochemie Gmbh Organic compounds
US20050037983A1 (en) * 2003-03-11 2005-02-17 Timothy Dinan Compositions and methods for the treatment of depression and other affective disorders
MXPA05010636A (es) * 2003-04-04 2005-12-12 Pharmacia Corp Comprimidos de multiparticulas preparados por compresion de liberacion oral prolongada.
FR2882522B1 (fr) 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine

Also Published As

Publication number Publication date
AU2006217814B2 (en) 2011-08-11
SI1855695T1 (sl) 2011-02-28
ES2354906T3 (es) 2011-03-21
CY1111129T1 (el) 2015-06-11
AR053144A1 (es) 2007-04-25
KR20070106581A (ko) 2007-11-01
DE602006017975D1 (de) 2010-12-16
MX2007010405A (es) 2007-10-17
FR2882522B1 (fr) 2007-04-13
IL185251A (en) 2012-10-31
RU2371184C2 (ru) 2009-10-27
IL185251A0 (en) 2008-02-09
EP1855695B1 (de) 2010-11-03
AU2006217814A1 (en) 2006-08-31
DK1855695T3 (da) 2011-02-21
FR2882522A1 (fr) 2006-09-01
ME01936B (en) 2016-10-19
US20080113020A1 (en) 2008-05-15
RU2007135367A (ru) 2009-03-27
US20130344151A1 (en) 2013-12-26
KR101346453B1 (ko) 2014-01-02
CN101180064A (zh) 2008-05-14
CA2598210A1 (fr) 2006-08-31
UY29403A1 (es) 2006-10-02
BRPI0608395A2 (pt) 2009-12-29
RS51578B (en) 2011-08-31
HRP20110089T1 (hr) 2011-03-31
PT1855695E (pt) 2011-01-19
TW200640472A (en) 2006-12-01
PL1855695T3 (pl) 2011-04-29
TWI371280B (en) 2012-09-01
JP5063368B2 (ja) 2012-10-31
HK1120412A1 (en) 2009-04-03
MY145394A (en) 2012-02-15
WO2006090067A1 (fr) 2006-08-31
CN101180064B (zh) 2010-09-22
EP1855695A1 (de) 2007-11-21
US8962021B2 (en) 2015-02-24
JP2008531529A (ja) 2008-08-14

Similar Documents

Publication Publication Date Title
RU2398586C3 (ru) Фармацевтическая композиция
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
NO20075628L (no) Farmasøytiske formuleringer
ATE517619T1 (de) Stabilisierte pharmazeutische zusammensetzung mit fesoterodin
BRPI0616703A2 (pt) forma de dosagem farmacêutica
BRPI0511900A (pt) composições farmacêuticas
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
DK1957073T3 (da) Lægemiddel
ATE453384T1 (de) Neue dosierformulierung
ATE493119T1 (de) Pharmazeutische zusammensetzung
IL186336A0 (en) Pharmaceutical composition
ATE483702T1 (de) Neue pharmazeutische verbindungen
DK1587478T3 (da) Farmaceutisk sammensætning
EP1937255A4 (de) Pharmazeutische zusammensetzung
ME01936B (en) Solid pharmaceutical composition comprising telithromycin
ATE480227T1 (de) Pharmazeutische zusammensetzungen mit quetiapinfumarat
EP1862184A4 (de) Pharmazeutische zusammensetzung
BRPI0614413A2 (pt) composto, e, composição farmacêutica
BRPI0614412A2 (pt) composto, e, composição farmacêutica
ATE552005T1 (de) Pharmazeutische zusammensetzung hyaluronan als aktive komponente enthaltend
DK1784174T3 (da) Famaceutisk sammensætning omfattende gabapentin
ATE489943T1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivate
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
ATE428416T1 (de) Feste pharmazeutische zubereitung enthaltend (r)- (-)-2-ä5-(4-fluorophenyl)-3- pyridylmethylaminomethylü-chroman
DE602004030921D1 (de) Pharmazeutische zusammensetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1855695

Country of ref document: EP